Phase 2 study for people with Alzheimer's Disease

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 13 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Celgene
Registry number NCT06808984
Started 9 June 2025 Today 16 October 2026 Estimated completion 26 November 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Local Institution - 0076 Macquarie Park NSW Not yet recruiting
Local Institution - 0090 Daw Park SA Not yet recruiting
Local Institution - 0078 Nedlands WA Not yet recruiting
Local Institution - 0077 Darlinghurst NSW Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 13 October 2026 · not medical advice

Who can join

Age 55 Years to 90 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 120

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria

* Participants with a diagnosis of Alzheimer's disease with biomarker confirmation meeting the 2024 Revised criteria for diagnosis and staging of AD: Alzheimer's Association Workgroup.

* The diagnosis of agitation must meet the International Psychogeriatric Association (IPA) definition of agitation.

* History of agitation with onset at least four weeks prior to Screening.

* MMSE-1 score ≤24.

* NPI-NH agitation/aggression sub-score ≥ 4.

* Stable living environment for at least 6 weeks prior to Screening. Participants are eligible if they are in nursing homes, assisted living facilities, or living at home and have an identified study partner (caregiver).

* Capable of self-locomotion (alone or with the aid of an assistive device); wheelchairs and other mobility aids are acceptable.

Exclusion Criteria

* Clinically significant delusions/hallucinations requiring hospitalization.

* History of bipolar disorder, schizophrenia, or schizoaffective disorder.

* History of major depressive episode with psychotic features during the 12 months prior to Screening.

* History of delirium within 30 days of Screening.

* Other protocol-defined Inclusion/Exclusion criteria apply.

Dates on the record

Started 9 June 2025
Estimated completion 26 November 2027
Registry last updated 6 October 2026
Checked by Voxsanity 13 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 6 October 2026.
  • This page last checked by Voxsanity: 13 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.